Profusa (PFSA) Cash from Operations (2022 - 2026)
Profusa's (PFSA) quarterly Cash from Operations came in at 2600000.0 in Q1 2026, down 384.17% year-on-year from 914941.02 in Q1 2025, and up 49.31% quarter-over-quarter from 5129000.0 in Q4 2025.
Profusa (PFSA) Cash from Operations (2022 - 2026) Analysis & Trends
Profusa's Cash from Operations history runs 5 years deep, the most recent figure standing at 2600000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 384.17% year-over-year to 2600000.0 in Q1 2026; TTM through Mar 2026 was 18311000.0, a 688.54% decrease from a year earlier, with the FY2025 full-year figure at 16248000.0, down 686.45% from the prior year.
- Cash from Operations improved to 2600000.0 in Q1 2026 per PFSA's latest filing, from 5129000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 35386.0 in Q2 2025 and bottomed at 10617386.0 in Q3 2025.
- The 5-year median for Cash from Operations is 345210.0 (2023), against an average of 1385885.24.
- Biggest YoY gain for Cash from Operations was 108.96% in 2025; the steepest drop was 2055.04% in 2025.
- Year by year, Cash from Operations stood at 179348.0 in 2022, then tumbled by 92.48% to 345210.0 in 2023, then soared by 31.06% to 238000.0 in 2024, then slumped by 2055.04% to 5129000.0 in 2025, then soared by 49.31% to 2600000.0 in 2026.
- Per Business Quant, the three latest PFSA Cash from Operations figures stand at 2600000.0 (Q1 2026), 5129000.0 (Q4 2025), and 10617386.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Profusa | 23,566.40 | -351,433.60 | - | -2.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.60 Mn |
| Mar 31, 2026 | -2.60 Mn |
| Dec 31, 2025 | -5.13 Mn |
| Dec 31, 2025 | -5.13 Mn |
| Sep 30, 2025 | -10.62 Mn |
| Sep 30, 2025 | -10.62 Mn |
| Jun 30, 2025 | 35,386.00 |
| Jun 30, 2025 | 35,386.00 |
| Mar 31, 2025 | -537,000.00 |
| Mar 31, 2025 | -537,000.00 |
| Dec 31, 2024 | -238,000.00 |
| Dec 31, 2024 | -238,000.00 |
| Sep 30, 2024 | -1.15 Mn |
| Sep 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | -394,878.00 |
| Jun 30, 2024 | -394,878.00 |
| Mar 31, 2024 | -280,853.00 |
| Mar 31, 2024 | -280,853.00 |
| Dec 31, 2023 | -345,210.00 |
| Dec 31, 2023 | -345,210.00 |